American College of Clinical Pharmacy
      Search      Cart
         

Clinical Reasoning Series in Ambulatory Care Pharmacy—Evidence-Based Screening and Prevention Strategies Program to Offer 6.0 Hours of BCACP Recertification Credit

From Theory to Practice: Clinical Reasoning Series

EVIDENCE-BASED SCREENING AND PREVENTION STRATEGIES

From Theory to Practice: Clinical Reasoning Series in Ambulatory Care Pharmacy

Saturday, October 12, 2013
8:30 a.m.–4:30 p.m.

ACCP 2013 Annual Meeting * October 13-16, 2013 * Albuquerque, New Mexico

About From Theory to Practice: Clinical Reasoning Series in Ambulatory Care Pharmacy

From Theory to Practice: Clinical Reasoning Series in Ambulatory Care Pharmacy is one component of the professional development program developed by ACCP and approved by the Board of Pharmacy Specialties (BPS) for the recertification of the Board Certified Ambulatory Care Pharmacist (BCACP).

This live education series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It provides participants with active learning exercises designed to advance their skills and abilities to critically evaluate scientific evidence and clinical trials and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.

More information on the BCACP recertification professional development program is available at www.accp.com/careers/boardbcacp.aspx.

Activity Overview

“Evidence-Based Screening and Prevention Strategies” will provide an overview of contemporary evidence-based screening and prevention strategies for cardiovascular diseases, type 2 diabetes mellitus, and chronic kidney disease in the ambulatory care setting.

Target Audience

Clinical pharmacists and BCACPs seeking recertification credit by continuing education

Continuing Pharmacy Education Credit

ACPE

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

This is an application-based activity; Activity Number: 0217-0000-13-109-L01-P.

To earn continuing pharmacy education credit and to receive your continuing pharmacy education statement of credit for this activity, participants must attend all 6.0 contact hours of programming and complete the associated evaluation at www.accp.com/ce. Partial credit is not available for this activity.

BCACP Recertification Credit

To be eligible for 6.0 CPE hours of recertification credit, BCACPs must attend all 6.0 contact hours of live programming and successfully complete a Web-based posttest by November 30, 2013. Partial credit is not available for this activity.

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Summarize important mechanisms and risk factors for the development of cardiovascular diseases, type 2 diabetes mellitus, and chronic kidney disease.
  2. Develop a comprehensive plan for screening patients with cardiovascular diseases, type 2 diabetes mellitus, and chronic kidney disease in the ambulatory care setting.
  3. Given a case, assess a patient’s risk for the development or progression of the above diseases.
  4. Formulate evidence-based recommendations for the primary and secondary prevention of each of the above diseases and complications.

Agenda

8:30 a.m. Introduction
8:45 a.m. Cardiovascular Diseases
10:15 a.m. Break
10:30 a.m. Type 2 Diabetes Mellitus
Noon Lunch
1:30 p.m. Chronic Kidney Disease
3:00 p.m. Break
3:15 p.m. Patient Cases and Panel Discussion
4:15 p.m. Closing Remarks

Learning objectives for each of the sessions are available at www.accp.com/meetings/am13/.

Program Faculty

Amy Barton Pai, Pharm.D., BCPS, FASN, FCCP Amy Barton Pai, Pharm.D., BCPS, FASN, FCCP
Associate Professor of Pharmacy Practice
Albany College of Pharmacy and Health Sciences
Adjunct Associate Professor of Internal Medicine, Division of Nephrology and Hypertension,
Albany Medical College
Albany, New York
Karen J. McConnell, Pharm.D., FCCP, BCPS (AQ Cardiology) Karen J. McConnell, Pharm.D., FCCP, BCPS (AQ Cardiology)
Clinical Pharmacy Specialist in Cardiology
Kaiser Permanente Colorado
Denver, Colorado
Julie M. Sease, Pharm.D., BCPS, CDE, BCACP Julie M. Sease, Pharm.D., BCPS, CDE, BCACP
Professor & Interim Assistant Dean for Academic Affairs
Presbyterian College School of Pharmacy
Clinton, South Carolina

Program Reviewers

Oralia V. Bazaldua, Pharm.D., FCCP, BCPS
Associate Professor
The University of Texas Health Science Center at San Antonio
Department of Family & Community Medicine
San Antonio, Texas

Katie E. Cardone, Pharm.D., BCACP, FNKF
Assistant Professor, Dept. of Pharmacy Practice
Albany Nephrology Pharmacy Group (ANephRx)
Albany College of Pharmacy and Health Sciences
Albany, New York

M. Shawn McFarland, Pharm.D., BCPS, BCACP, BC-ADM
Associate Service Chief of Pharmacy, Clinical & Educational Programs
Clinical Pharmacy Specialist Primary Care
Residency Program Director-PGY-2 Ambulatory Care Residency
VA Tennessee Valley Healthcare System, Alvin C. York Campus
Associate Professor
University of Tennessee College of Pharmacy
Murfreesboro, Tennessee

Registration Fee

  Early
(September 6)
Late
(September 27)
On-site
ACCP Member $200 $255 $295
Nonmember $315 $370 $410

Registration fee includes program booklet, CPE credit, and access to the BCACP recertification posttest.

Full information on the agenda, learning objectives, faculty, and registration is available at www.accp.com/meetings/am13/.

No commercial support has been received for this activity.

Cookies

This website uses cookies to help ACCP provide you with the best user experience. If you continue to use our services, ACCP will assume that you agree to the use of such cookies. You can find out how to update your settings by referring to ACCP’s Policy on Cookies.